علاج اعتلال الشبكية السكري بعد فشل التخثير الضوئي والعلاج بمضادات VEGF في تحقيق تراجع تكوّن الأوعية الجديدة

References

• When new vessels are accompanied by vitreous hemorrhage, or when NVD occupy greater than or equal to about one-quarter to one-third disc area, even in the absence of vitreous hemorrhage, PDR is considered high-risk.
• Patients with neovascular glaucoma or high-risk PDR should receive prompt treatment with anti-VEGF agents and PRP (see Care Process and Glossary).
• Pars plana vitrectomy should be considered for patients with PDR and vitreous opacities interfering with vision or treatment, severe fibrovascular proliferation, and tractional retinal detachment that is threatening or involving the macula.
• The DRVS demonstrated improved outcomes if vitrectomy for vitreous hemorrhage is done within 1 to 6 months of onset compared with later vitrectomy at 1 year.